Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07357454 · ClinicalTrials.gov registry record · NA
Smart Talk: Cannabis Awareness and Prevention Curriculum Evaluation
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 10,800
- Enrollment target
NCT07357454: Clinical Trial NA study, sponsored by Stanford University.
NCT07357454 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 10,800 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (670% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07357454, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 10,800 participants
- Enrollment target
Study Summary
The Stanford REACH Lab's SMART TALK: Cannabis Awareness and Prevention Toolkit is a free, online educational resource to be used by educators to increase knowledge and awareness of cannabis and reduce use among youth. The aim of this study is to investigate the extent to which the curriculum changes middle and high school students' intentions to use and actual use of cannabis.
Primary Outcome
Investigator-originated survey measures (questions) assess ever cannabis use \& past 30-day cannabis use. This outcome measure assesses cannabis use.
Interventions
- BEHAVIORAL Behavioral: Smart Talk Cannabis Awareness and Prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,800 participants |
| Start Date | 2026-09 |
| Est. Completion | 2030-02 |
| Phase | NA |
What is known before NCT07357454 opens enrollment
NCT07357454 is an interventional study that assigns participants to a tested intervention. Its 10,800 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (670% higher).
The record links to 0 conditions, and to 1 intervention - of which Behavioral: Smart Talk Cannabis Awareness and Prevention is the first listed.
NCT07357454 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07357454 about?
NCT07357454 is a clinical study titled "Smart Talk: Cannabis Awareness and Prevention Curriculum Evaluation". The Stanford REACH Lab's SMART TALK: Cannabis Awareness and Prevention Toolkit is a free, online educational resource to be used by educators to increase knowledge and awareness of cannabis and reduce use among youth. The aim of this study is to investigate the extent to which the curriculum changes...
What is the current status of trial NCT07357454?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 10,800 participants. The study started on 2026-09. Estimated completion is 2030-02.
What interventions are being tested in trial NCT07357454?
The interventions under investigation include: Behavioral: Smart Talk Cannabis Awareness and Prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07357454?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07357454's enrollment target sits among peer trials
10,800 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- NCT06736951 · 10,890 participants · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia